Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ANI Pharmaceuticals Inc

+ Add to Watchlist

ANIP:US

62.9300 USD 0.9900 1.60%

As of 20:10:00 ET on 03/30/2015.

Snapshot for ANI Pharmaceuticals Inc (ANIP)

Open: 62.8500 Day's Range: 62.3100 - 64.2100 Volume: 184,884
Previous Close: 61.9400 52wk Range: 19.9000 - 71.7800 1-Yr Rtn: +100.73%

Stock Chart for ANIP

No chart data available.
  • ANIP:US 62.9300
  • 1D
  • 1M
  • 1Y
61.9400
Interactive ANIP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ANIP

Current P/E Ratio (ttm) 24.8735
Estimated P/E(12/2015) 22.5556
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) 2.5300
Est. EPS (USD) (12/2015) 2.7900
Est. PEG Ratio -
Market Cap (M USD) 717.33
Shares Outstanding (M) 11.39
30 Day Average Volume 402,777
Price/Book (mrq) 5.1316
Price/Sale (ttm) 12.3537
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ANIP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ANIP

ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company. The Company develops, manufactures and markets branded and generic prescription pharmaceuticals. ANI manufactures oral solid dose products, as well as liquids and topicals.

Robert E Brown JrChairmanArthur S PrzybylPresident/CEO
Charlotte C ArnoldVP/CFORobert SchrepferVP:New Business Dev & Contract Mfg
More Company Profile & Key Executives for ANIP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil